nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—SLC22A1—Cladribine—multiple sclerosis	0.251	0.348	CbGbCtD
Acebutolol—CYP2D6—Fingolimod—multiple sclerosis	0.112	0.156	CbGbCtD
Acebutolol—ABCB1—Methylprednisolone—multiple sclerosis	0.0769	0.106	CbGbCtD
Acebutolol—ABCB1—Mitoxantrone—multiple sclerosis	0.0561	0.0777	CbGbCtD
Acebutolol—ABCB1—Betamethasone—multiple sclerosis	0.05	0.0692	CbGbCtD
Acebutolol—ABCB1—Prednisolone—multiple sclerosis	0.0493	0.0683	CbGbCtD
Acebutolol—ABCB1—Prednisone—multiple sclerosis	0.0466	0.0645	CbGbCtD
Acebutolol—ABCB1—Dexamethasone—multiple sclerosis	0.0291	0.0403	CbGbCtD
Acebutolol—CYP2D6—Dexamethasone—multiple sclerosis	0.0274	0.0379	CbGbCtD
Acebutolol—ABCB1—Methotrexate—multiple sclerosis	0.0234	0.0324	CbGbCtD
Acebutolol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000349	0.00131	CcSEcCtD
Acebutolol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000348	0.00131	CcSEcCtD
Acebutolol—Shock—Prednisolone—multiple sclerosis	0.000347	0.0013	CcSEcCtD
Acebutolol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000347	0.0013	CcSEcCtD
Acebutolol—Cough—Triamcinolone—multiple sclerosis	0.000347	0.0013	CcSEcCtD
Acebutolol—Urticaria—Mitoxantrone—multiple sclerosis	0.000341	0.00128	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000341	0.00128	CcSEcCtD
Acebutolol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00034	0.00127	CcSEcCtD
Acebutolol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00034	0.00127	CcSEcCtD
Acebutolol—Myalgia—Triamcinolone—multiple sclerosis	0.000338	0.00127	CcSEcCtD
Acebutolol—Vomiting—Azathioprine—multiple sclerosis	0.000338	0.00127	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—multiple sclerosis	0.000338	0.00127	CcSEcCtD
Acebutolol—Myalgia—Methylprednisolone—multiple sclerosis	0.000338	0.00127	CcSEcCtD
Acebutolol—Arthralgia—Methylprednisolone—multiple sclerosis	0.000338	0.00127	CcSEcCtD
Acebutolol—Anxiety—Methylprednisolone—multiple sclerosis	0.000336	0.00126	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—multiple sclerosis	0.000336	0.00126	CcSEcCtD
Acebutolol—Rash—Azathioprine—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Dermatitis—Azathioprine—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Depression—Methotrexate—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Flushing—Prednisone—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000335	0.00126	CcSEcCtD
Acebutolol—Discomfort—Triamcinolone—multiple sclerosis	0.000334	0.00125	CcSEcCtD
Acebutolol—Discomfort—Methylprednisolone—multiple sclerosis	0.000333	0.00125	CcSEcCtD
Acebutolol—Headache—Azathioprine—multiple sclerosis	0.000333	0.00125	CcSEcCtD
Acebutolol—Angiopathy—Prednisone—multiple sclerosis	0.000327	0.00123	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—multiple sclerosis	0.000326	0.00122	CcSEcCtD
Acebutolol—Confusional state—Methylprednisolone—multiple sclerosis	0.000326	0.00122	CcSEcCtD
Acebutolol—Malaise—Dexamethasone—multiple sclerosis	0.000325	0.00122	CcSEcCtD
Acebutolol—Malaise—Betamethasone—multiple sclerosis	0.000325	0.00122	CcSEcCtD
Acebutolol—Oedema—Triamcinolone—multiple sclerosis	0.000324	0.00122	CcSEcCtD
Acebutolol—Vertigo—Dexamethasone—multiple sclerosis	0.000324	0.00122	CcSEcCtD
Acebutolol—Vertigo—Betamethasone—multiple sclerosis	0.000324	0.00122	CcSEcCtD
Acebutolol—Syncope—Dexamethasone—multiple sclerosis	0.000323	0.00121	CcSEcCtD
Acebutolol—Syncope—Betamethasone—multiple sclerosis	0.000323	0.00121	CcSEcCtD
Acebutolol—Sweating—Methotrexate—multiple sclerosis	0.000322	0.00121	CcSEcCtD
Acebutolol—Shock—Triamcinolone—multiple sclerosis	0.000319	0.0012	CcSEcCtD
Acebutolol—Insomnia—Prednisolone—multiple sclerosis	0.000319	0.0012	CcSEcCtD
Acebutolol—Alopecia—Prednisone—multiple sclerosis	0.000319	0.0012	CcSEcCtD
Acebutolol—Shock—Methylprednisolone—multiple sclerosis	0.000318	0.00119	CcSEcCtD
Acebutolol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000317	0.00119	CcSEcCtD
Acebutolol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000317	0.00119	CcSEcCtD
Acebutolol—Loss of consciousness—Betamethasone—multiple sclerosis	0.000317	0.00119	CcSEcCtD
Acebutolol—Paraesthesia—Prednisolone—multiple sclerosis	0.000317	0.00119	CcSEcCtD
Acebutolol—Nausea—Azathioprine—multiple sclerosis	0.000316	0.00118	CcSEcCtD
Acebutolol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000314	0.00118	CcSEcCtD
Acebutolol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000313	0.00118	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—multiple sclerosis	0.000313	0.00118	CcSEcCtD
Acebutolol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000313	0.00117	CcSEcCtD
Acebutolol—Asthenia—Mitoxantrone—multiple sclerosis	0.000308	0.00116	CcSEcCtD
Acebutolol—Myalgia—Betamethasone—multiple sclerosis	0.000307	0.00115	CcSEcCtD
Acebutolol—Myalgia—Dexamethasone—multiple sclerosis	0.000307	0.00115	CcSEcCtD
Acebutolol—Anxiety—Dexamethasone—multiple sclerosis	0.000306	0.00115	CcSEcCtD
Acebutolol—Anxiety—Betamethasone—multiple sclerosis	0.000306	0.00115	CcSEcCtD
Acebutolol—Discomfort—Dexamethasone—multiple sclerosis	0.000303	0.00114	CcSEcCtD
Acebutolol—Discomfort—Betamethasone—multiple sclerosis	0.000303	0.00114	CcSEcCtD
Acebutolol—Hypotension—Methylprednisolone—multiple sclerosis	0.000302	0.00113	CcSEcCtD
Acebutolol—Pain—Prednisolone—multiple sclerosis	0.000302	0.00113	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—multiple sclerosis	0.000299	0.00112	CcSEcCtD
Acebutolol—Vision blurred—Prednisone—multiple sclerosis	0.000296	0.00111	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000295	0.00111	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000295	0.00111	CcSEcCtD
Acebutolol—Oedema—Dexamethasone—multiple sclerosis	0.000294	0.0011	CcSEcCtD
Acebutolol—Oedema—Betamethasone—multiple sclerosis	0.000294	0.0011	CcSEcCtD
Acebutolol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000294	0.0011	CcSEcCtD
Acebutolol—Insomnia—Triamcinolone—multiple sclerosis	0.000293	0.0011	CcSEcCtD
Acebutolol—Insomnia—Methylprednisolone—multiple sclerosis	0.000293	0.0011	CcSEcCtD
Acebutolol—Ill-defined disorder—Prednisone—multiple sclerosis	0.000291	0.00109	CcSEcCtD
Acebutolol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000291	0.00109	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000291	0.00109	CcSEcCtD
Acebutolol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000291	0.00109	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—multiple sclerosis	0.00029	0.00109	CcSEcCtD
Acebutolol—Shock—Dexamethasone—multiple sclerosis	0.000289	0.00109	CcSEcCtD
Acebutolol—Shock—Betamethasone—multiple sclerosis	0.000289	0.00109	CcSEcCtD
Acebutolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000289	0.00108	CcSEcCtD
Acebutolol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000289	0.00108	CcSEcCtD
Acebutolol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000289	0.00108	CcSEcCtD
Acebutolol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000285	0.00107	CcSEcCtD
Acebutolol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000285	0.00107	CcSEcCtD
Acebutolol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000284	0.00107	CcSEcCtD
Acebutolol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000284	0.00107	CcSEcCtD
Acebutolol—Malaise—Prednisone—multiple sclerosis	0.000283	0.00106	CcSEcCtD
Acebutolol—Vertigo—Prednisone—multiple sclerosis	0.000282	0.00106	CcSEcCtD
Acebutolol—Syncope—Prednisone—multiple sclerosis	0.000282	0.00106	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—multiple sclerosis	0.000281	0.00105	CcSEcCtD
Acebutolol—Anorexia—Betamethasone—multiple sclerosis	0.00028	0.00105	CcSEcCtD
Acebutolol—Anorexia—Dexamethasone—multiple sclerosis	0.00028	0.00105	CcSEcCtD
Acebutolol—Urticaria—Prednisolone—multiple sclerosis	0.00028	0.00105	CcSEcCtD
Acebutolol—Fatigue—Triamcinolone—multiple sclerosis	0.00028	0.00105	CcSEcCtD
Acebutolol—Fatigue—Methylprednisolone—multiple sclerosis	0.000279	0.00105	CcSEcCtD
Acebutolol—Pain—Triamcinolone—multiple sclerosis	0.000277	0.00104	CcSEcCtD
Acebutolol—Loss of consciousness—Prednisone—multiple sclerosis	0.000276	0.00104	CcSEcCtD
Acebutolol—Hypotension—Dexamethasone—multiple sclerosis	0.000275	0.00103	CcSEcCtD
Acebutolol—Hypotension—Betamethasone—multiple sclerosis	0.000275	0.00103	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—multiple sclerosis	0.000273	0.00103	CcSEcCtD
Acebutolol—Vomiting—Mitoxantrone—multiple sclerosis	0.000273	0.00103	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000272	0.00102	CcSEcCtD
Acebutolol—Rash—Mitoxantrone—multiple sclerosis	0.000271	0.00102	CcSEcCtD
Acebutolol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000271	0.00102	CcSEcCtD
Acebutolol—Chills—Methotrexate—multiple sclerosis	0.00027	0.00101	CcSEcCtD
Acebutolol—Headache—Mitoxantrone—multiple sclerosis	0.000269	0.00101	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000268	0.00101	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000268	0.00101	CcSEcCtD
Acebutolol—Arthralgia—Prednisone—multiple sclerosis	0.000267	0.001	CcSEcCtD
Acebutolol—Myalgia—Prednisone—multiple sclerosis	0.000267	0.001	CcSEcCtD
Acebutolol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000267	0.001	CcSEcCtD
Acebutolol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000267	0.001	CcSEcCtD
Acebutolol—Anxiety—Prednisone—multiple sclerosis	0.000266	0.000999	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—multiple sclerosis	0.000266	0.000999	CcSEcCtD
Acebutolol—Insomnia—Betamethasone—multiple sclerosis	0.000266	0.000999	CcSEcCtD
Acebutolol—Insomnia—Dexamethasone—multiple sclerosis	0.000266	0.000999	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000265	0.000996	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000265	0.000993	CcSEcCtD
Acebutolol—Paraesthesia—Betamethasone—multiple sclerosis	0.000264	0.000991	CcSEcCtD
Acebutolol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000264	0.000991	CcSEcCtD
Acebutolol—Discomfort—Prednisone—multiple sclerosis	0.000264	0.000991	CcSEcCtD
Acebutolol—Dyspepsia—Betamethasone—multiple sclerosis	0.000259	0.000972	CcSEcCtD
Acebutolol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000259	0.000972	CcSEcCtD
Acebutolol—Urticaria—Triamcinolone—multiple sclerosis	0.000258	0.000967	CcSEcCtD
Acebutolol—Urticaria—Methylprednisolone—multiple sclerosis	0.000257	0.000964	CcSEcCtD
Acebutolol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000256	0.000962	CcSEcCtD
Acebutolol—Oedema—Prednisone—multiple sclerosis	0.000256	0.000961	CcSEcCtD
Acebutolol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000256	0.00096	CcSEcCtD
Acebutolol—Decreased appetite—Betamethasone—multiple sclerosis	0.000256	0.00096	CcSEcCtD
Acebutolol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000256	0.00096	CcSEcCtD
Acebutolol—Nausea—Mitoxantrone—multiple sclerosis	0.000255	0.000958	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000254	0.000953	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000254	0.000953	CcSEcCtD
Acebutolol—Back pain—Methotrexate—multiple sclerosis	0.000254	0.000952	CcSEcCtD
Acebutolol—Fatigue—Dexamethasone—multiple sclerosis	0.000254	0.000952	CcSEcCtD
Acebutolol—Fatigue—Betamethasone—multiple sclerosis	0.000254	0.000952	CcSEcCtD
Acebutolol—Shock—Prednisone—multiple sclerosis	0.000252	0.000946	CcSEcCtD
Acebutolol—Pain—Dexamethasone—multiple sclerosis	0.000252	0.000944	CcSEcCtD
Acebutolol—Pain—Betamethasone—multiple sclerosis	0.000252	0.000944	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—multiple sclerosis	0.000251	0.000943	CcSEcCtD
Acebutolol—Skin disorder—Prednisone—multiple sclerosis	0.000249	0.000934	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000248	0.000929	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—multiple sclerosis	0.000247	0.000928	CcSEcCtD
Acebutolol—Anorexia—Prednisone—multiple sclerosis	0.000244	0.000916	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000243	0.000913	CcSEcCtD
Acebutolol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000242	0.00091	CcSEcCtD
Acebutolol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000242	0.00091	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000241	0.000903	CcSEcCtD
Acebutolol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000241	0.000903	CcSEcCtD
Acebutolol—Malaise—Methotrexate—multiple sclerosis	0.000237	0.000888	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—multiple sclerosis	0.000236	0.000885	CcSEcCtD
Acebutolol—Urticaria—Dexamethasone—multiple sclerosis	0.000234	0.000877	CcSEcCtD
Acebutolol—Urticaria—Betamethasone—multiple sclerosis	0.000234	0.000877	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000233	0.000876	CcSEcCtD
Acebutolol—Dizziness—Prednisolone—multiple sclerosis	0.000233	0.000875	CcSEcCtD
Acebutolol—Asthenia—Triamcinolone—multiple sclerosis	0.000233	0.000873	CcSEcCtD
Acebutolol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000233	0.000873	CcSEcCtD
Acebutolol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000233	0.000873	CcSEcCtD
Acebutolol—Abdominal pain—Betamethasone—multiple sclerosis	0.000233	0.000873	CcSEcCtD
Acebutolol—Body temperature increased—Betamethasone—multiple sclerosis	0.000233	0.000873	CcSEcCtD
Acebutolol—Asthenia—Methylprednisolone—multiple sclerosis	0.000232	0.000871	CcSEcCtD
Acebutolol—Insomnia—Prednisone—multiple sclerosis	0.000232	0.00087	CcSEcCtD
Acebutolol—Paraesthesia—Prednisone—multiple sclerosis	0.00023	0.000863	CcSEcCtD
Acebutolol—Pruritus—Triamcinolone—multiple sclerosis	0.000229	0.000861	CcSEcCtD
Acebutolol—Cough—Methotrexate—multiple sclerosis	0.000229	0.000859	CcSEcCtD
Acebutolol—Pruritus—Methylprednisolone—multiple sclerosis	0.000229	0.000859	CcSEcCtD
Acebutolol—Dyspepsia—Prednisone—multiple sclerosis	0.000226	0.000846	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—multiple sclerosis	0.000223	0.000838	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—multiple sclerosis	0.000223	0.000838	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—multiple sclerosis	0.000223	0.000838	CcSEcCtD
Acebutolol—Decreased appetite—Prednisone—multiple sclerosis	0.000223	0.000836	CcSEcCtD
Acebutolol—Rash—Prednisolone—multiple sclerosis	0.000222	0.000834	CcSEcCtD
Acebutolol—Dermatitis—Prednisolone—multiple sclerosis	0.000222	0.000833	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000222	0.000832	CcSEcCtD
Acebutolol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000221	0.000831	CcSEcCtD
Acebutolol—Fatigue—Prednisone—multiple sclerosis	0.000221	0.000829	CcSEcCtD
Acebutolol—Headache—Prednisolone—multiple sclerosis	0.000221	0.000829	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—multiple sclerosis	0.000221	0.000828	CcSEcCtD
Acebutolol—Constipation—Prednisone—multiple sclerosis	0.000219	0.000822	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—multiple sclerosis	0.000216	0.00081	CcSEcCtD
Acebutolol—Dizziness—Triamcinolone—multiple sclerosis	0.000214	0.000805	CcSEcCtD
Acebutolol—Dizziness—Methylprednisolone—multiple sclerosis	0.000214	0.000803	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisone—multiple sclerosis	0.000211	0.000792	CcSEcCtD
Acebutolol—Asthenia—Dexamethasone—multiple sclerosis	0.000211	0.000792	CcSEcCtD
Acebutolol—Asthenia—Betamethasone—multiple sclerosis	0.000211	0.000792	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—multiple sclerosis	0.00021	0.000788	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00021	0.000786	CcSEcCtD
Acebutolol—Nausea—Prednisolone—multiple sclerosis	0.000209	0.000786	CcSEcCtD
Acebutolol—Pruritus—Betamethasone—multiple sclerosis	0.000208	0.000781	CcSEcCtD
Acebutolol—Pruritus—Dexamethasone—multiple sclerosis	0.000208	0.000781	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—multiple sclerosis	0.000208	0.00078	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000207	0.000777	CcSEcCtD
Acebutolol—Vomiting—Triamcinolone—multiple sclerosis	0.000206	0.000774	CcSEcCtD
Acebutolol—Vomiting—Methylprednisolone—multiple sclerosis	0.000206	0.000772	CcSEcCtD
Acebutolol—Rash—Triamcinolone—multiple sclerosis	0.000204	0.000767	CcSEcCtD
Acebutolol—Dermatitis—Triamcinolone—multiple sclerosis	0.000204	0.000766	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—multiple sclerosis	0.000204	0.000766	CcSEcCtD
Acebutolol—Rash—Methylprednisolone—multiple sclerosis	0.000204	0.000765	CcSEcCtD
Acebutolol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000204	0.000765	CcSEcCtD
Acebutolol—Urticaria—Prednisone—multiple sclerosis	0.000204	0.000764	CcSEcCtD
Acebutolol—Headache—Triamcinolone—multiple sclerosis	0.000203	0.000762	CcSEcCtD
Acebutolol—Headache—Methylprednisolone—multiple sclerosis	0.000203	0.000761	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—multiple sclerosis	0.000203	0.00076	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—multiple sclerosis	0.000203	0.00076	CcSEcCtD
Acebutolol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000201	0.000755	CcSEcCtD
Acebutolol—Diarrhoea—Betamethasone—multiple sclerosis	0.000201	0.000755	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—multiple sclerosis	0.0002	0.000751	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000195	0.000732	CcSEcCtD
Acebutolol—Dizziness—Betamethasone—multiple sclerosis	0.000195	0.00073	CcSEcCtD
Acebutolol—Dizziness—Dexamethasone—multiple sclerosis	0.000195	0.00073	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—multiple sclerosis	0.000194	0.000727	CcSEcCtD
Acebutolol—Nausea—Triamcinolone—multiple sclerosis	0.000193	0.000723	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—multiple sclerosis	0.000192	0.000721	CcSEcCtD
Acebutolol—Nausea—Methylprednisolone—multiple sclerosis	0.000192	0.000721	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—multiple sclerosis	0.000191	0.000716	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—multiple sclerosis	0.00019	0.000714	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—multiple sclerosis	0.000189	0.000707	CcSEcCtD
Acebutolol—Vomiting—Dexamethasone—multiple sclerosis	0.000187	0.000702	CcSEcCtD
Acebutolol—Vomiting—Betamethasone—multiple sclerosis	0.000187	0.000702	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—multiple sclerosis	0.000186	0.000698	CcSEcCtD
Acebutolol—Rash—Betamethasone—multiple sclerosis	0.000186	0.000696	CcSEcCtD
Acebutolol—Rash—Dexamethasone—multiple sclerosis	0.000186	0.000696	CcSEcCtD
Acebutolol—Dermatitis—Betamethasone—multiple sclerosis	0.000185	0.000695	CcSEcCtD
Acebutolol—Dermatitis—Dexamethasone—multiple sclerosis	0.000185	0.000695	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000185	0.000694	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—multiple sclerosis	0.000185	0.000693	CcSEcCtD
Acebutolol—Headache—Betamethasone—multiple sclerosis	0.000184	0.000692	CcSEcCtD
Acebutolol—Headache—Dexamethasone—multiple sclerosis	0.000184	0.000692	CcSEcCtD
Acebutolol—Asthenia—Prednisone—multiple sclerosis	0.000184	0.00069	CcSEcCtD
Acebutolol—Pain—Methotrexate—multiple sclerosis	0.000183	0.000687	CcSEcCtD
Acebutolol—Pruritus—Prednisone—multiple sclerosis	0.000181	0.00068	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000176	0.000662	CcSEcCtD
Acebutolol—Diarrhoea—Prednisone—multiple sclerosis	0.000175	0.000658	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000175	0.000657	CcSEcCtD
Acebutolol—Nausea—Dexamethasone—multiple sclerosis	0.000175	0.000656	CcSEcCtD
Acebutolol—Nausea—Betamethasone—multiple sclerosis	0.000175	0.000656	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—multiple sclerosis	0.00017	0.000638	CcSEcCtD
Acebutolol—Dizziness—Prednisone—multiple sclerosis	0.000169	0.000636	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—multiple sclerosis	0.000169	0.000635	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—multiple sclerosis	0.000169	0.000635	CcSEcCtD
Acebutolol—Vomiting—Prednisone—multiple sclerosis	0.000163	0.000611	CcSEcCtD
Acebutolol—Rash—Prednisone—multiple sclerosis	0.000162	0.000606	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—multiple sclerosis	0.000161	0.000606	CcSEcCtD
Acebutolol—Headache—Prednisone—multiple sclerosis	0.000161	0.000602	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—multiple sclerosis	0.000154	0.000576	CcSEcCtD
Acebutolol—Nausea—Prednisone—multiple sclerosis	0.000152	0.000571	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—multiple sclerosis	0.000152	0.000568	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—multiple sclerosis	0.000147	0.00055	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—multiple sclerosis	0.000142	0.000531	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—multiple sclerosis	0.000136	0.000511	CcSEcCtD
Acebutolol—Rash—Methotrexate—multiple sclerosis	0.000135	0.000507	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—multiple sclerosis	0.000135	0.000506	CcSEcCtD
Acebutolol—Headache—Methotrexate—multiple sclerosis	0.000134	0.000503	CcSEcCtD
Acebutolol—Nausea—Methotrexate—multiple sclerosis	0.000127	0.000477	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—CCR1—multiple sclerosis	4.57e-05	0.00391	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	4.51e-05	0.00386	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CD86—multiple sclerosis	4.49e-05	0.00384	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	4.4e-05	0.00377	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL10—multiple sclerosis	4.4e-05	0.00377	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	4.37e-05	0.00374	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL4—multiple sclerosis	4.28e-05	0.00367	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	4.27e-05	0.00366	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	4.25e-05	0.00364	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	4.2e-05	0.0036	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	4.19e-05	0.00358	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	4.17e-05	0.00357	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	4.16e-05	0.00356	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	4.11e-05	0.00352	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	4.08e-05	0.00349	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	4.06e-05	0.00348	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	3.97e-05	0.0034	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	3.95e-05	0.00338	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	3.95e-05	0.00338	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	3.92e-05	0.00336	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	3.88e-05	0.00332	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	3.86e-05	0.00331	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.77e-05	0.00323	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—BCHE—multiple sclerosis	3.74e-05	0.0032	CbGpPWpGaD
Acebutolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.65e-05	0.00313	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	3.65e-05	0.00312	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	3.58e-05	0.00306	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	3.57e-05	0.00305	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.54e-05	0.00303	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	3.5e-05	0.003	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	3.33e-05	0.00285	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	3.28e-05	0.00281	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	3.27e-05	0.0028	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	3.25e-05	0.00279	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	3.25e-05	0.00278	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	3.21e-05	0.00275	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	3.2e-05	0.00274	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	3.18e-05	0.00272	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	3.13e-05	0.00268	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	3.09e-05	0.00265	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SRM—multiple sclerosis	3.07e-05	0.00263	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	3.04e-05	0.0026	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	3.02e-05	0.00259	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	3.01e-05	0.00258	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.98e-05	0.00255	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	2.98e-05	0.00255	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	2.97e-05	0.00254	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.96e-05	0.00254	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	2.94e-05	0.00252	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.91e-05	0.0025	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	2.91e-05	0.00249	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	2.88e-05	0.00247	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.83e-05	0.00243	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	2.83e-05	0.00242	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	2.82e-05	0.00242	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	2.78e-05	0.00238	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	2.76e-05	0.00237	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	2.76e-05	0.00237	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	2.72e-05	0.00232	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	2.7e-05	0.00231	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	2.64e-05	0.00226	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	2.64e-05	0.00226	CbGpPWpGaD
Acebutolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.64e-05	0.00226	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.63e-05	0.00225	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	2.62e-05	0.00224	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.59e-05	0.00222	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	2.58e-05	0.00221	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	2.58e-05	0.00221	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	2.56e-05	0.00219	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.55e-05	0.00218	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	2.53e-05	0.00217	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	2.5e-05	0.00214	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.49e-05	0.00213	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	2.48e-05	0.00212	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	2.44e-05	0.00209	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	2.4e-05	0.00205	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	2.4e-05	0.00205	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	2.34e-05	0.00201	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	2.34e-05	0.00201	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.31e-05	0.00198	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.3e-05	0.00197	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.28e-05	0.00195	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.21e-05	0.00189	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	2.2e-05	0.00188	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	2.17e-05	0.00185	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	2.17e-05	0.00185	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	2.15e-05	0.00184	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	2.15e-05	0.00184	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	2.1e-05	0.0018	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.99e-05	0.0017	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPC5—multiple sclerosis	1.98e-05	0.0017	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.95e-05	0.00167	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.95e-05	0.00167	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.95e-05	0.00167	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	1.94e-05	0.00166	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	1.92e-05	0.00164	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.9e-05	0.00163	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	1.9e-05	0.00162	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	1.88e-05	0.00161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	1.87e-05	0.0016	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.87e-05	0.0016	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	1.83e-05	0.00156	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	1.81e-05	0.00155	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SRM—multiple sclerosis	1.8e-05	0.00154	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.79e-05	0.00154	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	1.77e-05	0.00152	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	1.75e-05	0.0015	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.75e-05	0.0015	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	1.71e-05	0.00146	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	1.71e-05	0.00146	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	1.7e-05	0.00146	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SRM—multiple sclerosis	1.7e-05	0.00145	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.68e-05	0.00143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	1.67e-05	0.00143	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	1.66e-05	0.00142	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	1.64e-05	0.00141	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—RRM1—multiple sclerosis	1.64e-05	0.00141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	1.63e-05	0.0014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	1.61e-05	0.00138	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	1.6e-05	0.00137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	1.59e-05	0.00136	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.57e-05	0.00135	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	1.57e-05	0.00134	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	1.55e-05	0.00133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	1.55e-05	0.00132	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.54e-05	0.00132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	1.54e-05	0.00132	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	1.53e-05	0.00131	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	1.51e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	1.51e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	1.51e-05	0.00129	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	1.48e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	1.48e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	1.45e-05	0.00124	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.43e-05	0.00122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	1.42e-05	0.00122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	1.42e-05	0.00121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	1.42e-05	0.00121	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.41e-05	0.00121	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	1.39e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	1.38e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	1.38e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.38e-05	0.00118	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	1.28e-05	0.0011	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.00109	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.00109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	1.25e-05	0.00107	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	1.22e-05	0.00104	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.00102	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	1.19e-05	0.00102	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.000994	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	1.1e-05	0.000945	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	1.1e-05	0.000938	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.09e-05	0.000937	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.09e-05	0.000937	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	1.08e-05	0.000925	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.08e-05	0.000924	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	1.07e-05	0.000917	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.06e-05	0.000904	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	1.01e-05	0.000863	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	9.95e-06	0.000852	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	9.86e-06	0.000844	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	9.8e-06	0.000839	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	9.73e-06	0.000833	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	9.71e-06	0.000831	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—RRM1—multiple sclerosis	9.62e-06	0.000824	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	9.59e-06	0.000821	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	9.56e-06	0.000818	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	9.49e-06	0.000813	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.48e-06	0.000812	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—BCHE—multiple sclerosis	9.43e-06	0.000807	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	9.37e-06	0.000803	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	9.35e-06	0.000801	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	9.29e-06	0.000795	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	9.17e-06	0.000785	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	9.12e-06	0.000781	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	9.08e-06	0.000778	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.06e-06	0.000776	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	8.92e-06	0.000764	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.88e-06	0.00076	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.85e-06	0.000758	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.68e-06	0.000743	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	8.56e-06	0.000733	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	8.42e-06	0.000721	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	8.37e-06	0.000717	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.27e-06	0.000708	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	8.23e-06	0.000705	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	7.77e-06	0.000666	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	7.61e-06	0.000651	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	7.6e-06	0.000651	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	7.58e-06	0.000649	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	7.44e-06	0.000637	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	7.41e-06	0.000635	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	6.91e-06	0.000591	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	6.76e-06	0.000578	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	6.63e-06	0.000567	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	6.52e-06	0.000558	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	6.48e-06	0.000555	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	6.38e-06	0.000546	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	6.33e-06	0.000542	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	6.19e-06	0.00053	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	6.04e-06	0.000517	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	5.91e-06	0.000506	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	5.88e-06	0.000503	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	5.79e-06	0.000496	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	5.75e-06	0.000492	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	5.75e-06	0.000492	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—multiple sclerosis	5.67e-06	0.000486	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	5.67e-06	0.000485	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	5.62e-06	0.000481	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.56e-06	0.000476	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BCHE—multiple sclerosis	5.52e-06	0.000473	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	5.35e-06	0.000458	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	5.23e-06	0.000448	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.21e-06	0.000446	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—POMC—multiple sclerosis	4.87e-06	0.000417	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	4.83e-06	0.000414	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	4.73e-06	0.000405	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	4.59e-06	0.000393	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	4.49e-06	0.000385	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	4.49e-06	0.000385	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—multiple sclerosis	4.44e-06	0.00038	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	4.4e-06	0.000376	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	4.4e-06	0.000376	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	4.3e-06	0.000368	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	4.08e-06	0.000349	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	3.99e-06	0.000342	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	3.4e-06	0.000291	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	3.38e-06	0.000289	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—multiple sclerosis	3.32e-06	0.000285	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	3.32e-06	0.000284	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	3.3e-06	0.000283	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	3.21e-06	0.000275	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	3.14e-06	0.000269	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—multiple sclerosis	3.13e-06	0.000268	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	2.86e-06	0.000245	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000244	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	2.79e-06	0.000239	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—POMC—multiple sclerosis	2.69e-06	0.00023	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	2.65e-06	0.000227	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	2.65e-06	0.000227	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—multiple sclerosis	2.6e-06	0.000223	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	2.6e-06	0.000222	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	2.6e-06	0.000222	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	2.59e-06	0.000222	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	2.54e-06	0.000218	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—multiple sclerosis	2.45e-06	0.00021	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	2e-06	0.000171	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	1.95e-06	0.000167	CbGpPWpGaD
